Related references
Note: Only part of the references are listed.HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia
Yanfei Tang et al.
GROWTH FACTORS (2023)
Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma
Su Il Kim et al.
MOLECULAR ONCOLOGY (2022)
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer
Lin Zhong et al.
CELL DEATH & DISEASE (2022)
Autophagy in acute myeloid leukemia: a paradoxical role in chemoresistance
Aafreen Khan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
LncRNA FGD5-AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR-223 and regulating the expression of ECT2 and FAT1
Chen-Kun He et al.
HEPATOLOGY RESEARCH (2022)
FAT1 downregulation enhances sternness and cisplatin resistance in esophageal squamous cell carcinoma
Yuanfang Zhai et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Dandan Peng et al.
MOLECULAR CANCER (2022)
Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment via TGF-β
Khushboo Irshad et al.
FRONTIERS IN IMMUNOLOGY (2022)
FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair
Ting Lan et al.
FRONTIERS IN ONCOLOGY (2022)
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Ievgenia Pastushenko et al.
NATURE (2021)
Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3
Yipei Jing et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation
Minjie Li et al.
ENVIRONMENTAL TOXICOLOGY (2021)
Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia
Yasuhiro Shingai et al.
STEM CELLS (2021)
AML poor prognosis factor, TPD52, is associated with the maintenance of haematopoietic stem cells through regulation of cell proliferation
Ji Wan Kang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer (vol 397, pg 83, 2017)
Xiaoling Hu et al.
CANCER LETTERS (2020)
Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo
Yuanyuan Fu et al.
AUTOPHAGY (2019)
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin et al.
NATURE COMMUNICATIONS (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells
Nan Zhang et al.
CANCER LETTERS (2017)
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
Jae-Sook Ahn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
FAT1: a potential target for monoclonal antibody therapy in colon cancer
Piero Pileri et al.
BRITISH JOURNAL OF CANCER (2016)
FAT1 is a novel upstream regulator of HIF1 and invasion of high grade glioma
Evanka Madan et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
Manoj Garg et al.
BLOOD (2015)
FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation
Abdulrzag F. Ahmed et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
ATG4B promotes colorectal cancer growth independent of autophagic flux
Pei-Feng Liu et al.
AUTOPHAGY (2014)
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
Marina Y. Konopleva et al.
CLINICAL CANCER RESEARCH (2014)
A Soluble Form of the Giant Cadherin Fat1 Is Released from Pancreatic Cancer Cells by ADAM10 Mediated Ectodomain Shedding
Nathalie Wojtalewicz et al.
PLOS ONE (2014)
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy
Steven Knapper et al.
BLOOD (2006)
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia
AM O'Farrell et al.
LEUKEMIA RESEARCH (2004)